Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

77.01 +3.30 (+4.48%)
Streaming Delayed Price Updated: 2:37 PM EDT, Mar 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ANI Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
ANIP Stock Earnings: ANI Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 ↗
ANIP stock results show that ANI Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Evaluating ANI Pharmaceuticals: Insights From 5 Financial Analysts ↗
 
Via Benzinga
News headline image
Alphabet, Dover And 2 Other Stocks Insiders Are Selling ↗
The Nasdaq 100 closed lower by around 1.5% on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
News headline image
Expert Outlook: ANI Pharmaceuticals Through The Eyes Of 4 Analysts ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 29, 2024 ↗
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
News headline image
Drug Maker Organon Stock Scores Relative Strength Upgrade ↗
In a welcome move, drug maker Organon stock saw its Relative Strength Rating rise from 66 to 71 on Wednesday. 
Via Investor's Business Daily
News headline image
ANI Pharmaceuticals's Earnings Outlook ↗
 
Via Benzinga
News headline image
Expert Ratings for ANI Pharmaceuticals ↗
 
Via Benzinga
News headline image
Analyst Expectations for ANI Pharmaceuticals's Future ↗
 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About ANI Pharmaceuticals ↗
 
Via Benzinga
News headline image
Truist Securities Maintains Buy Rating for ANI Pharmaceuticals: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Why Is Generic Drug Player ANI Pharmaceuticals Stock Trading Lower Today? ↗
ANI Pharmaceuticals Inc's (NASDAQ: ANIP) third-quarter revenues were $131.8 million, up 57.3% Y/Y, beating the  
Via Benzinga
ANI Pharmaceuticals Inc. (NASDAQ: ANIP) Records 52-Week High Wednesday Morning
Via Investor Brand Network
News headline image
7 A-Rated Biotech Stocks for Your August Buy List ↗
Investing in biotech stocks means accepting a long R&D window, but the rewards when your A-rated biotech stocks come through are huge. 
Via InvestorPlace
News headline image
Where ANI Pharmaceuticals Stands With Analysts ↗
 
Via Benzinga
News headline image
Looking Into ANI Pharmaceuticals's Return On Capital Employed ↗
 
Via Benzinga
News headline image
Why ANI Pharmaceuticals Stock Is Soaring Today ↗
ANI Pharmaceuticals Inc's (NASDAQ: ANIP) Q1 revenues were $106.8 million, +65.6% Y/Y, beating the  
Via Benzinga
News headline image
Earnings Preview For ANI Pharmaceuticals ↗
 
Via Benzinga
News headline image
ANI Pharmaceuticals to Present at the Jefferies Healthcare Conference
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
ANI Pharmaceuticals Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
ANI Pharmaceuticals Announces FDA Approval and Commercialization of Two ANDAs with CGT Exclusivity
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
ANI Pharmaceuticals Announces Pricing of $75 Million Public Offering of Common Stock
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
ANI Pharmaceuticals Announces Proposed Public Offering of Common Stock
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
Stocks Reverse Gains Ahead Of Slew Of Inflation Data ↗
Stocks are lower this afternoon, as investors await a deluge of inflation data amid a rally for the banking sector. 
Via Talk Markets
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Trevena, Inc. (NASDAQ: TRVN) shares surged 170% to $1.74 after the company announced the approval of OLINVYK in China. 
Via Benzinga
News headline image
ANI Pharmaceuticals to Discuss First Quarter 2023 Financial Results on May 8, 2023, at 8:30 a.m. ET
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
ANI Pharmaceuticals to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
ANI Pharmaceuticals Announces the FDA Approval and Launch of Nitrofurantoin Oral Suspension USP
From ANI Pharmaceuticals, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.